Constitutive GABA expression via a recombinant adeno-associated virus consistently attenuates neuropathic pain

Boyoung Lee, Jaehyung Kim, Sung Jin Kim, Heuiran Lee, Jin Woo Chang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Peripheral neuropathic pain is a common clinical problem with few existing treatments. Previously, we constructed rAAV bearing GAD65 and demonstrated that GAD65 and GABA can be constitutively produced in the CNS. To investigate the beneficial effects of GAD65 produced by rAAV and resulting GABA release in peripheral neuropathic pain, we established a neuropathic pain rat model. The direct administration of rAAV-GAD65 to dorsal root ganglion induced constitutive GAD65 expression, which was readily detected by immunohistochemistry. Both allodynic and hyperalgeic behavior tests suggested that neuropathic pain was noticeably reduced, along with the transgenic GAD65 expression. Moreover, the magnitude of pain relief was maintained during the entire experimental period. Concomitantly, the significant enhancement in GABA release following transgenic GAD65 expression was identified in vivo. Taken all together, these results provide evidence that persistent GAD65 and subsequent GABA expression in DRGs via rAAV effectively attenuates peripheral neuropathic pain for long period of time.

Original languageEnglish
Pages (from-to)971-976
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume357
Issue number4
DOIs
Publication statusPublished - 2007 Jun 15

Fingerprint

Dependovirus
Neuralgia
Viruses
gamma-Aminobutyric Acid
Bearings (structural)
Diagnosis-Related Groups
Spinal Ganglia
Rats
Immunohistochemistry
Pain

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{fbc84be08a7344da8d1f23fc6f221945,
title = "Constitutive GABA expression via a recombinant adeno-associated virus consistently attenuates neuropathic pain",
abstract = "Peripheral neuropathic pain is a common clinical problem with few existing treatments. Previously, we constructed rAAV bearing GAD65 and demonstrated that GAD65 and GABA can be constitutively produced in the CNS. To investigate the beneficial effects of GAD65 produced by rAAV and resulting GABA release in peripheral neuropathic pain, we established a neuropathic pain rat model. The direct administration of rAAV-GAD65 to dorsal root ganglion induced constitutive GAD65 expression, which was readily detected by immunohistochemistry. Both allodynic and hyperalgeic behavior tests suggested that neuropathic pain was noticeably reduced, along with the transgenic GAD65 expression. Moreover, the magnitude of pain relief was maintained during the entire experimental period. Concomitantly, the significant enhancement in GABA release following transgenic GAD65 expression was identified in vivo. Taken all together, these results provide evidence that persistent GAD65 and subsequent GABA expression in DRGs via rAAV effectively attenuates peripheral neuropathic pain for long period of time.",
author = "Boyoung Lee and Jaehyung Kim and Kim, {Sung Jin} and Heuiran Lee and Chang, {Jin Woo}",
year = "2007",
month = "6",
day = "15",
doi = "10.1016/j.bbrc.2007.04.061",
language = "English",
volume = "357",
pages = "971--976",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

Constitutive GABA expression via a recombinant adeno-associated virus consistently attenuates neuropathic pain. / Lee, Boyoung; Kim, Jaehyung; Kim, Sung Jin; Lee, Heuiran; Chang, Jin Woo.

In: Biochemical and Biophysical Research Communications, Vol. 357, No. 4, 15.06.2007, p. 971-976.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Constitutive GABA expression via a recombinant adeno-associated virus consistently attenuates neuropathic pain

AU - Lee, Boyoung

AU - Kim, Jaehyung

AU - Kim, Sung Jin

AU - Lee, Heuiran

AU - Chang, Jin Woo

PY - 2007/6/15

Y1 - 2007/6/15

N2 - Peripheral neuropathic pain is a common clinical problem with few existing treatments. Previously, we constructed rAAV bearing GAD65 and demonstrated that GAD65 and GABA can be constitutively produced in the CNS. To investigate the beneficial effects of GAD65 produced by rAAV and resulting GABA release in peripheral neuropathic pain, we established a neuropathic pain rat model. The direct administration of rAAV-GAD65 to dorsal root ganglion induced constitutive GAD65 expression, which was readily detected by immunohistochemistry. Both allodynic and hyperalgeic behavior tests suggested that neuropathic pain was noticeably reduced, along with the transgenic GAD65 expression. Moreover, the magnitude of pain relief was maintained during the entire experimental period. Concomitantly, the significant enhancement in GABA release following transgenic GAD65 expression was identified in vivo. Taken all together, these results provide evidence that persistent GAD65 and subsequent GABA expression in DRGs via rAAV effectively attenuates peripheral neuropathic pain for long period of time.

AB - Peripheral neuropathic pain is a common clinical problem with few existing treatments. Previously, we constructed rAAV bearing GAD65 and demonstrated that GAD65 and GABA can be constitutively produced in the CNS. To investigate the beneficial effects of GAD65 produced by rAAV and resulting GABA release in peripheral neuropathic pain, we established a neuropathic pain rat model. The direct administration of rAAV-GAD65 to dorsal root ganglion induced constitutive GAD65 expression, which was readily detected by immunohistochemistry. Both allodynic and hyperalgeic behavior tests suggested that neuropathic pain was noticeably reduced, along with the transgenic GAD65 expression. Moreover, the magnitude of pain relief was maintained during the entire experimental period. Concomitantly, the significant enhancement in GABA release following transgenic GAD65 expression was identified in vivo. Taken all together, these results provide evidence that persistent GAD65 and subsequent GABA expression in DRGs via rAAV effectively attenuates peripheral neuropathic pain for long period of time.

UR - http://www.scopus.com/inward/record.url?scp=34247889863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247889863&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2007.04.061

DO - 10.1016/j.bbrc.2007.04.061

M3 - Article

C2 - 17466264

AN - SCOPUS:34247889863

VL - 357

SP - 971

EP - 976

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -